TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26 16:49 | 8/5/26 | CRL | Charles River Laboratories International, Inc. | Health | Biolab | Commercial Physical & Biologi | 2 | 2 | S | -18,202 | 227.40 | 0 | -80 | 276 | D | ||||||||||||||||
8/6/26 16:02 | 8/4/26 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | 2 | 3 | S.d | -440 | 14.38 | 0 | -31 | 104 | D | |||||||||||||||
8/5/26 16:11 | 8/3/26 | ULS | Ul Solutions Inc. | DE | Health | Biolab | Testing Laboratories | 5 | 9 | S.dm | -7,951 | 98.71 | 0 | -81 | 379 | D | |||||||||||||||
8/4/26 17:00 | 8/3/26 | IQV | Iqvia Holdings Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 5 | 5 | S.d | -29,191 | 244.91 | 0 | -119 | 1,418 | D | |||||||||||||||
8/4/26 16:04 | 7/31/26 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | 6 | 8 | S.dm | -13,057 | 113.80 | 0 | -115 | 424 | D | |||||||||||||||
7/29/26 16:36 | 7/28/26 | MEDP | Medpace Holdings, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 3 | 3 | S.dm | -16,203 | 521.22 | 0 | -31 | 5,455 | D | |||||||||||||||
6/12/26 17:33 | 5/6/26 | BUDZ | Weed, Inc. | NV | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | S.m | -3 | 0.0312 | 0 | -111 | 0 | 30,100 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |